尿液[TIMP-2]•[IGFBP7]用于急诊识别脓毒症相关急性肾损伤
这项单中心前瞻性观察研究纳入急诊疑似感染且NEWS 2≥3的成人患者,在急诊停留期间留取首次尿样检测[TIMP-2]•[IGFBP7],24小时内按KDIGO定义评估中重度AKI。入院时尿液[TIMP-2]•[IGFBP7]升高与24小时内中重度AKI发生相关(校正OR 1.24,95%CI 1.07-1.43,P<0.01),但整体区分度仅中等(AUC 0.67)。预设界值显示互补诊断价值:<0.3时阴性预测值0.86,>2.0时增加AKI可能性。肌酐轨迹与炎症指标组间大体相似,仅高风险患者IL-10与IL-1RN升高。
要点
- 急诊疑似感染且NEWS 2≥3的成人患者中,尿液[TIMP-2]•[IGFBP7]升高与24小时内中重度AKI相关(校正OR 1.24,95%CI 1.07-1.43,P<0.01)。
- 该标志物整体区分度仅中等(AUC 0.67),不宜单独作为脓毒症相关AKI的诊断依据。
- 预设界值<0.3时阴性预测值0.86,可用于排除24小时内发生中重度AKI的风险。
- 预设界值>2.0提示中重度AKI高风险,需加强监测与预防。
- 肌酐轨迹与炎症指标组间大体相似,仅高风险患者IL-10与IL-1RN升高。
适用人群与场景
- 急诊科就诊的疑似感染成人患者,且NEWS 2评分≥3分。
诊断标准与关键阈值
- AKI按KDIGO定义判定。
- 尿液[TIMP-2]•[IGFBP7]预设界值:<0.3(阴性预测值0.86,用于排除AKI)与>2.0(提示高风险)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 单中心前瞻性观察研究,纳入急诊疑似感染且NEWS 2≥3的成人患者,急诊停留期间留取首次尿样检测[TIMP-2]•[IGFBP7],24小时内抽三次血并按KDIGO定义判定AKI。
- 入院时尿液[TIMP-2]•[IGFBP7]升高与24小时内中重度AKI相关(校正OR 1.24;95%CI 1.07-1.43;P<0.01)。
- 整体区分度中等(AUC 0.67)。
- 预设界值<0.3时阴性预测值0.86,>2.0时增加AKI可能性。
- 肌酐轨迹与炎症指标组间大体相似,仅高风险患者IL-10与IL-1RN升高。
证据类型、等级与局限
- 证据类型:单中心、前瞻性、观察性研究。
- 局限:单中心设计,样本量原文未提及,整体区分度仅中等(AUC 0.67)。
对床旁实践的改变
- 在急诊疑似感染且NEWS 2≥3的成人患者中,尿液[TIMP-2]•[IGFBP7]<0.3可辅助排除24小时内中重度AKI(NPV 0.86),>2.0提示高风险需加强监测。
- 因整体区分度仅中等(AUC 0.67),不应单独依据该标志物诊断或排除脓毒症相关AKI。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Acute kidney injury (AKI) is a common and harmful syndrome associated with sepsis. It is difficult to predict and has an adverse impact on both short- and long-term prognosis. Two urinary biomarkers, tissue inhibitor of metalloproteinases-2 (TIMP-2), and insulin-like growth factor-binding protein 7 (IGFBP7) have been validated for predicting moderate and severe AKI and improving the recognition of organ failure in critically ill patients with sepsis. We aimed to evaluate the performance of these markers for predicting sepsis-related AKI and its evolution in a cohort of patients admitted to the Emergency Department with infectious disease and high risk of sepsis. This single-centre, prospective, observational study included adult patients presenting to the Emergency Department (ED) with suspected infection. Patients were included in the study if they had a National Early Warning Score 2 (NEWS 2) of 3 or higher. Three blood samples were drawn during the first 24 h, and we defined AKI according to the Kidney Disease: Improving Global Outcomes (KDIGO) definition. The first urine sample during ED stay was collected for urinary [TIMP-2]•[ IGFBP7] determination. Higher admission levels of urinary [TIMP-2]•[IGFBP7] were associated with the development of AKI moderate-severe within 24 h (adjusted Odds Ratio 1.24; 95% Confidence Interval 1.07-1.43; p < 0.01). The biomarker showed only modest overall discrimination (AUC 0.67). Still, predefined cut-offs revealed complementary diagnostic roles: low values (<0.3) may help exclude AKI with a negative predictive value of 0.86, whereas the highest values (>2.0) increase its likelihood. Creatinine trajectories and inflammatory profiles were largely similar across groups, except for elevations in IL-10 and IL-1RN in high-risk patients. In conclusion, urinary [TIMP-2]•[IGFBP7] measured on presentation to the ED had only moderate discrimination for sepsis-associated AKI. However, values (<0.3 units) could help to rule out the risk of developing AKI, while values >2.0 indicated high risk.
参考来源
- Cisteró B, Monforte V, Navas A, et al. Use of [TIMP-2] • [IGFBP7] to identify sepsis-related acute kidney injury in the emergency department. Ann Intensive Care. 2026. PMID: 42565116. doi:10.1016/j.aicoj.2026.100119
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。